These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [Differences in anti-oncogene p53 expression in human monocytes and lymphocytes in vitro]. Osipovich OA; Sudarikov AB; Kolesnikova TS; Misuno NI; Voĭtenok NN Biull Eksp Biol Med; 1992 Jun; 113(6):638-40. PubMed ID: 1446038 [TBL] [Abstract][Full Text] [Related]
43. Neutralization of pyrogen-induced tumour necrosis factor by its type 1 soluble receptor in guinea-pigs: effects on fever and interleukin-6 release. Roth J; Martin D; Störr B; Zeisberger E J Physiol; 1998 May; 509 ( Pt 1)(Pt 1):267-75. PubMed ID: 9547399 [TBL] [Abstract][Full Text] [Related]
44. Fever and production of cytokines in response to repeated injections of muramyl dipeptide in guinea-pigs. Roth J; Hopkins SJ; Hoadley ME; Tripp A; Aslan T; Störr B; Luheshi GN; Zeisberger E Pflugers Arch; 1997 Sep; 434(5):525-33. PubMed ID: 9242715 [TBL] [Abstract][Full Text] [Related]
45. Effect of cisplatin, rIFN-Y, LPS and MDP on release of H2O2, O2- and lysozyme from human monocytes in vitro. Pai K; Sodhi A Indian J Exp Biol; 1991 Oct; 29(10):910-5. PubMed ID: 1667647 [TBL] [Abstract][Full Text] [Related]
46. Potentiation of direct antitumor cytotoxicity and production of tumor cytolytic factors in human blood monocytes by human recombinant interferon-gamma and muramyl dipeptide derivatives. Sone S; Lopez-Berestein G; Fidler IJ Cancer Immunol Immunother; 1986; 21(2):93-9. PubMed ID: 3081250 [TBL] [Abstract][Full Text] [Related]
47. Modulation of cytokine production by some phthalimido-desmuramyl dipeptides and their cytotoxicity. Gobec S; Sollner-Dolenc M; Urleb U; Wraber B; Simcic S; Filipic M Farmaco; 2004 May; 59(5):345-52. PubMed ID: 15120313 [TBL] [Abstract][Full Text] [Related]
48. Activation of human monocytes by free muramyl dipeptide (MDP). Kildahl-Andersen O; Seim S Acta Pathol Microbiol Immunol Scand C; 1984 Jun; 92(3):181-7. PubMed ID: 6507104 [TBL] [Abstract][Full Text] [Related]
49. Differential induction of human monocyte transforming growth factor beta 1 production and its regulation by interleukin 4. Miller-Graziano CL; Zhu D; Kodys K J Clin Immunol; 1994 Jan; 14(1):61-72. PubMed ID: 8132738 [TBL] [Abstract][Full Text] [Related]
50. Scavenger receptor-mediated delivery of muramyl dipeptide activates antitumor efficacy of macrophages by enhanced secretion of tumor-suppressive cytokines. Srividya S; Roy RP; Basu SK; Mukhopadhyay A J Leukoc Biol; 2000 May; 67(5):683-90. PubMed ID: 10811009 [TBL] [Abstract][Full Text] [Related]
51. Opposite effect of Interferon-gamma on PGE2 release from Interleukin-1-stimulated human monocytes or fibroblasts. Friteau L; Francesconi E; Lando D; Dugas B; Damais C Biochem Biophys Res Commun; 1988 Dec; 157(3):1197-204. PubMed ID: 3144968 [TBL] [Abstract][Full Text] [Related]
52. G(Anh)MTetra, a natural bacterial cell wall breakdown product, induces interleukin-1 beta and interleukin-6 expression in human monocytes. A study of the molecular mechanisms involved in inflammatory cytokine expression. Dokter WH; Dijkstra AJ; Koopmans SB; Stulp BK; Keck W; Halie MR; Vellenga E J Biol Chem; 1994 Feb; 269(6):4201-6. PubMed ID: 8307982 [TBL] [Abstract][Full Text] [Related]
53. Induction of necrosis factor-alpha and interleukin-6 in mice in vivo and in murine peritoneal macrophages and human whole blood cells in vitro by Micrococcus luteus teichuronic acids. Monodane T; Kawabata Y; Yang S; Hase S; Takada H J Med Microbiol; 2001 Jan; 50(1):4-12. PubMed ID: 11192503 [TBL] [Abstract][Full Text] [Related]
54. Induction, in vivo and in vitro, of macrophage membrane interleukin-1 by adjuvant-active synthetic muramyl peptides. Bahr GM; Chedid LA; Behbehani K Cell Immunol; 1987 Jul; 107(2):443-54. PubMed ID: 3496165 [TBL] [Abstract][Full Text] [Related]
55. ImmTher, a lipophilic disaccharide derivative of muramyl dipeptide, up-regulates specific monocyte cytokine genes and activates monocyte-mediated tumoricidal activity. Worth LL; Jia SF; An T; Kleinerman ES Cancer Immunol Immunother; 1999 Sep; 48(6):312-20. PubMed ID: 10473806 [TBL] [Abstract][Full Text] [Related]
56. Effect of muramyl peptides and tumor necrosis factor on oxidative responses of human blood phagocytes. Jupin C; Parant M; Chedid L Immunol Lett; 1989 Sep; 22(3):187-92. PubMed ID: 2553589 [TBL] [Abstract][Full Text] [Related]
57. A tumor necrosis factor (TNF) receptor fragment attenuates TNF-alpha- and muramyl dipeptide-induced sleep and fever in rabbits. Takahashi S; Kapás L; Krueger JM J Sleep Res; 1996 Jun; 5(2):106-14. PubMed ID: 8795811 [TBL] [Abstract][Full Text] [Related]
58. Leukotriene B4 up-regulates IL-6 rather than IL-1 synthesis in human monocytes. Poubelle PE; Stankova J; Grassi J; Rola-Pleszczynski M Agents Actions; 1991 Sep; 34(1-2):42-5. PubMed ID: 1665302 [TBL] [Abstract][Full Text] [Related]
59. Increased expression of alkaline phosphatase activity in stimulated B lymphocytes by muramyl dipeptide. Souvannavong V; Adam A Immunol Lett; 1990 Jul; 24(4):247-51. PubMed ID: 2391133 [TBL] [Abstract][Full Text] [Related]
60. Modulation of muramyl dipeptide stimulation of cytokine production by blood components. van der Meer JH; Netea MG; Dinarello CA Clin Exp Immunol; 2009 Jun; 156(3):428-33. PubMed ID: 19438594 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]